000489348 000__ 01574cam\a2200361\a\4500
000489348 001__ 489348
000489348 005__ 20210513171845.0
000489348 006__ m\\\\\o\\d\\\\\\\\
000489348 007__ cr\cn|||||||||
000489348 008__ 100617s2010\\\\nyu\\\\\ob\\\\001\0\eng\d
000489348 010__ $$z  2010025918
000489348 020__ $$z9781617288517 (softcover)
000489348 020__ $$z9781617610332 (e-book)
000489348 035__ $$a(CaPaEBR)ebr10680970
000489348 035__ $$a(OCoLC)704284839
000489348 040__ $$aCaPaEBR$$cCaPaEBR
000489348 05014 $$aRC848.H425$$bF34 2010eb
000489348 08204 $$a616.3/623$$222
000489348 1001_ $$aFahim, Magid A.
000489348 24510 $$aHepatitis C infection in dialysis$$h[electronic resource] /$$cMagid A. Fahim and David W. Johnson.
000489348 260__ $$aNew York :$$bNova Biomedical Books/Novinka,$$cc2010.
000489348 300__ $$a46 p.
000489348 4901_ $$aNephrology research and clinical developments
000489348 504__ $$aIncludes bibliographical references (p. [35]-41) and index.
000489348 5050_ $$aEpidemiology -- Risk factors for HCV acquisition in haemodialysis patients -- Prevention of HCV transmission in haemodialysis units -- Diagnosis, screening, and evaluation -- Hepatic pathology and complications -- Treatment and monitoring -- Outcomes.
000489348 506__ $$aAccess limited to authorized users.
000489348 650_0 $$aHepatitis C.
000489348 650_0 $$aHemodialysis$$xComplications.
000489348 7001_ $$aJohnson, David W.$$q(David Wayne),$$d1964-
000489348 830_0 $$aNephrology research and clinical developments series.
000489348 852__ $$bebk
000489348 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10680970$$zOnline Access
000489348 909CO $$ooai:library.usi.edu:489348$$pGLOBAL_SET
000489348 980__ $$aEBOOK
000489348 980__ $$aBIB
000489348 982__ $$aEbook
000489348 983__ $$aOnline